Immunoadsorption in severe C4d-positive acute kidney allograft rejection: A randomized controlled trial

American Journal of Transplantation

Volumn 7, Issue 1, 2007, Pages 117-121

  Bohmig G A ^a   Wahrmann, M ^a   Regele, H ^a   Exner, M ^a   Robl, B ^a   Derfler, K ^a   Soliman, T ^a   Bauer, P ^a   Mullner M ^a   Druml, W ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Alloantibody; C4d; Immunoadsorption; Kidney transplantation; Rejection; Treatment

Indexed keywords

ALLOANTIBODY; COMPLEMENT COMPONENT C4D; GANCICLOVIR; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; CYTOMEGALOVIRUS INFECTION; DRUG SAFETY; GRAFT FAILURE; GRAFT NECROSIS; GRAFT RECIPIENT; HUMAN; HUMAN TISSUE; IMMUNOADSORPTION; KIDNEY ALLOGRAFT REJECTION; KIDNEY BIOPSY; KIDNEY TRANSPLANTATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RENAL REPLACEMENT THERAPY;

ADULT; AGED; COMPLEMENT C4B; GRAFT REJECTION; HUMANS; IMMUNOTHERAPY; KIDNEY TRANSPLANTATION; MIDDLE AGED; NECROSIS; PEPTIDE FRAGMENTS; RENAL DIALYSIS; STAPHYLOCOCCAL PROTEIN A; TACROLIMUS; TREATMENT OUTCOME;

EID: 33845682514     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2006.01613.x     Document Type: Article

References (23)

1. Halloran PF, Schlaut J, Solez K, Srinivasa NS. The significance of the anti-class I response. II. Clinical and pathologic features of renal transplants with anti-class I-like antibody. Transplantation 1992; 53(3): 550-555.
2. Feucht HE, Schneeberger H, Hillebrand G, Burkhardt K, Weiss M, Riethmüller G et al. Capillary deposition of C4d complement fragment and early renal graft loss. Kidney Int 1993; 43(6): 1333-1338.
3. Terasaki PI. Humoral theory of transplantation. Am J Transplant 2003; 3(6): 665-673.
4. Cardella CJ, Sutton DM, Falk JA, Katz A, Uldall PR, deVeber GA. Effect of intensive plasma exchange on renal transplant rejection and serum cytotoxic antibody. Transplant Proc 1978; 10(3): 617-619.
5. Kirubakaran MG, Disney AP, Norman J, Pugsley DJ, Mathew TH. A controlled trial of plasmapheresis in the treatment of renal allograft rejection. Transplantation 1981; 32(2): 164-165.
6. Soulillou JP, Guyot C, Guimbretiere J et al. Plasma exchange in early kidney graft rejection associated with anti-donor antibodies. Nephron 1983; 35(3): 158-162.
7. Allen NH, Dyer P, Geoghegan T, Harris K, Lee HA, Slapak M. Plasma exchange in acute renal allograft rejection. A controlled trial. Transplantation 1983; 35(5): 425-428.
8. Bonomini V, Vangelista A, Frasca GM, Di Felice A, Liviano D'Arcangelo G. Effects of plasmapheresis in renal transplant rejection. A controlled study. Trans Am Soc Artif Intern Organs 1985; 31: 698-703.
9. Pascual M, Saidman S, Tolkoff-Rubin N et al. Plasma exchange and tacrolimus-mycophenolate rescue for acute humoral rejection in kidney transplantation. Transplantation 1998; 66(11): 1460-1464.
10. Montgomery RA, Zachary AA, Racusen LC et al. Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients. Transplantation 2000; 70(6): 887-895.
11. Takemoto SK, Zeevi A, Feng S et al. National conference to assess antibody-mediated rejection in solid organ transplantation. Am J Transplant 2004; 4(7): 1033-1041.
12. Pretagostini R, Berloco P, Poli L et al. Immunoadsorption with protein A in humoral rejection of kidney transplants. Asaio J 1996; 42(5): M645-M648.
13. Böhmig GA, Regele H, Exner M et al. C4d-positive acute humoral renal allograft rejection: Effective treatment by immunoadsorption. J Am Soc Nephrol 2001; 12(11): 2482-2489.
14. Nickeleit V, Zeiler M, Gudat F, Thiel G, Mihatsch MJ. Detection of the complement degradation product C4d in renal allografts: diagnostic and therapeutic implications. J Am Soc Nephrol 2002; 13(1): 242-251.
15. Sun Q, Liu ZH, Yin G et al. Tacrolimus combined with mycophenolate mofetil can effectively reverse C4d-positive steroid-resistant acute rejection in Chinese renal allograft recipients. Nephrol Dial Transplant 2006; 21(2): 510-517.
16. Lorenz M, Regele H, Schillinger M et al. Peritransplant immunoadsorption: A strategy enabling transplantation in highly sensitized crossmatch-positive cadaveric kidney allograft recipients. Transplantation 2005; 79(6): 696-701.
17. Racusen LC, Solez K, Colvin RB et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55(2): 713-723.
18. Racusen LC, Colvin RB, Solez K et al. Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection. Am J Transplant 2003; 3(6): 708-714.
19. Khan N, Robson AJ, Worthington JE, Martin S. The detection and definition of IgM alloantibodies in the presence of IgM autoantibodies using flowPRA beads. Hum Immunol 2003; 64(6): 593-599.
20. Glotz D, Antoine C, Julia P et al. Desensitization and subsequent kidney transplantation of patients using intravenous immunoglobulins (IVIg). Am J Transplant 2002; 2(8): 758-760.
21. Magil AB, Tinckam KJ. Focal peritubular capillary C4d deposition in acute rejection. Nephrol Dial Transplant 2006; 21: 1382-1388.
22. Mauiyyedi S, Crespo M, Collins AB et al. Acute humoral rejection in kidney transplantation: II. Morphology, immunopathology, and pathologic classification. J Am Soc Nephrol 2002; 13(3): 779-787.
23. Martin L, Guignier F, Mousson C, Rageot D, Justrabo E, Rifle G. Detection of donor-specific anti-HLA antibodies with flow cytometry in eluates and sera from renal transplant recipients with chronic allograft nephropathy. Transplantation 2003; 76(2): 395-400.